FLT3LG and hepatocellular carcinoma: EMX1-FL, but not EMX1-X1, promotes the migration, invasion, and metastasis of HCC in vivo and in vitro by activating EGFR transcription and EGFR-ERK signaling, while blocking the EGFR signals can reverse these effects and reduce HCC metastasis.